PHYSIOLOGICAL-RESPONSES, ORGAN DISTRIBUTION, AND CIRCULATION KINETICS IN ANESTHETIZED RATS AFTER HYPOVOLEMIC EXCHANGE-TRANSFUSION WITH TC-99M-LABELED LIPOSOME-ENCAPSULATED HEMOGLOBIN

被引:16
作者
GOINS, B
KLIPPER, R
SANDERS, J
CLIFF, RO
RUDOLPH, AS
PHILLIPS, WT
机构
[1] UNIV TEXAS,HLTH SCI CTR,DEPT RADIOL,SAN ANTONIO,TX 78284
[2] USN,RES LAB,CTR BIOMOLEC SCI & ENGN,WASHINGTON,DC 20375
来源
SHOCK | 1995年 / 4卷 / 02期
关键词
D O I
10.1097/00024382-199508000-00008
中图分类号
R4 [临床医学];
学科分类号
1002 [临床医学]; 100602 [中西医结合临床];
摘要
Physiological responses and circulation properties of liposome-encapsulated hemoglobin (LEH) labeled with technetium-99m Tc-99m) were measured in rats after a 10% (170 mg/kg hemoglobin, 430 mg/kg phospholipid) or a 50% (450 mg/kg hemoglobin, 2.3 g/kg phospholipid) hypovolemic exchange transfusion (n = 5 per exchange group). Mean arterial pressure returned to baseline values (105 +/- 8 mmHg) by 90 min post-infusion for both groups. By 20 h, mean arterial pressure remained at baseline values for the 10% group, but dropped to 30 +/- 14 mmHg for the 50% group. For both groups, bradycardia was seen after the exchange period, but heart rate recovered by 30 min for the 10% group and by 90 min for the 50% group. The (99m) Tc-99m-LEH remained in circulation longer for the 50% group (18.2 h half-life) than for the 10% group (2.4 h half-life). Removal of Tc-99m-LEK from the bloodstream was via the liver and spleen. At 20 h, Tc-99m-LEH accumulation in these organs was greater for the 10% group (liver, 36.2 +/- 1.7%; spleen, 37.5 +/- 2.5%) than for the 50% group (liver, 17.0 +/- 1.4%; spleen, 17.1 +/- 1.4%). The data show that there is less clearance of Tc-99m-LEH from the bloodstream by the reticuloendothelial system after a 50% hypovolemic exchange transfusion, thus supporting the possible use of LEH as an oxygen-carrying resuscitative fluid in situations of severe blood loss.
引用
收藏
页码:121 / 130
页数:10
相关论文
共 35 条
[1]
ALTURA BM, 1985, RETICULOENDOTHELIAL, P355
[2]
ASAKURA T, 1985, OXYGEN TRANSPORT RED, P57
[3]
BEACH MC, 1993, BLOOD SUBSTITUTES OX, P548
[4]
BLEEKER WK, 1989, J LAB CLIN MED, V113, P151
[5]
ASSESSMENT OF BLOOD SUBSTITUTES .1. EFFICACY STUDIES IN ANESTHETIZED AND CONSCIOUS RATS WITH LOSS OF 1/3, 1/2 AND 2/3 BLOOD-VOLUME [J].
CHANG, TMS ;
VARMA, R .
ARTIFICIAL CELLS BLOOD SUBSTITUTES AND IMMOBILIZATION BIOTECHNOLOGY, 1994, 22 (02) :159-169
[6]
CARDIORESPIRATORY EFFECTS OF EXCHANGE TRANSFUSIONS WITH SYNTHETIC ERYTHROCYTES IN RATS [J].
DJORDJEVICH, L ;
MAYORAL, J ;
MILLER, IF ;
IVANKOVICH, AD .
CRITICAL CARE MEDICINE, 1987, 15 (04) :318-323
[7]
FARMER MC, 1987, METHOD ENZYMOL, V149, P184
[8]
BIOCOMPATIBILITY OF HEMOGLOBIN-SOLUTIONS .1. REACTIONS OF VASCULAR ENDOTHELIAL-CELLS TO PURE AND IMPURE HEMOGLOBINS [J].
FEOLA, M ;
SIMONI, J ;
FISHMAN, D ;
TRAN, R ;
CANIZARO, PC .
ARTIFICIAL ORGANS, 1989, 13 (03) :209-215
[9]
NEPHROTOXICITY OF HEMOGLOBIN-SOLUTIONS [J].
FEOLA, M ;
SIMONI, J ;
TRAN, R ;
CANIZARO, PC .
BIOMATERIALS ARTIFICIAL CELLS AND ARTIFICIAL ORGANS, 1990, 18 (02) :233-249
[10]
FRANK DW, 1976, HDB LAB ANIMAL SCI, P23